T.K. v. Novo Nordisk: Saxenda Gallbladder Removal Settlement
A 38-year-old patient who required gallbladder removal after developing severe gallbladder disease during Saxenda treatment received a $650,000 settlement.
Case Background
T.K., a 38-year-old woman from Wilmington, Delaware, was prescribed Saxenda in June 2022 for weight management. She had a BMI of 34 and no prior history of gallbladder issues.
After approximately 5 months of Saxenda treatment, T.K. began experiencing severe right upper quadrant abdominal pain, nausea, and vomiting. She was diagnosed with acute cholecystitis (gallbladder inflammation) caused by gallstones.
Medical Diagnosis and Treatment
T.K. was diagnosed with acute cholecystitis based on:
- Abdominal ultrasound showing gallstones and gallbladder wall thickening
- Elevated liver enzymes and bilirubin
- Clinical symptoms including severe right upper quadrant pain, fever, and nausea
She underwent laparoscopic cholecystectomy (gallbladder removal) in November 2022. Post-surgery, she developed post-cholecystectomy syndrome, experiencing ongoing digestive issues including diarrhea, bloating, and food intolerance.
Legal Proceedings
T.K. filed a lawsuit against Novo Nordisk in June 2023, alleging that the company failed to adequately warn about the risk of gallbladder disease requiring surgical removal.
Key Evidence
- Medical records showing no prior gallbladder issues before Saxenda use
- Expert testimony from a gastroenterologist and bariatric medicine specialist
- FDA adverse event reports showing a significant number of gallbladder cases associated with liraglutide
- Clinical trial data showing increased rates of gallbladder events in Saxenda-treated patients
Legal Hurdles
Novo Nordisk argued that T.K.'s weight loss — approximately 25 pounds over 5 months — was the primary cause of her gallbladder disease, as rapid weight loss is a well-known risk factor for gallstone formation. However, expert testimony established that:
- The rate of weight loss was moderate, not extreme
- The clinical trial data for Saxenda showed gallbladder events at rates higher than would be expected from weight loss alone
- Liraglutide has known pharmacological effects on gallbladder motility
- The timing of gallbladder disease onset correlated with Saxenda use
Settlement
After 5 months of litigation, Novo Nordisk agreed to a $650,000 settlement. The settlement covered:
- Surgical costs: $85,000
- Post-cholecystectomy syndrome treatment: $65,000
- Lost wages: $100,000
- Pain and suffering and permanent dietary restrictions: $400,000
T.K. continues to experience digestive issues related to gallbladder removal and must follow a permanent low-fat diet.
Legal Hurdles
Novo Nordisk argued that the patient's weight loss itself could have caused gallbladder issues, as rapid weight loss is a known risk factor for gallstones. Expert testimony established that the rapid development of gallbladder disease, combined with the known pharmacological effects of liraglutide on gallbladder function, supported causation.
Outcome
Settled for $650,000. The settlement covered surgical costs ($85,000), post-cholecystectomy syndrome treatment ($65,000), lost wages ($100,000), and compensation for permanent dietary restrictions and pain and suffering ($400,000).
Frequently Asked Questions
I had my gallbladder removed after taking Saxenda. Do I have a case?
If you required gallbladder removal (cholecystectomy) after taking Saxenda, you may have a valid legal claim. Gallbladder removal is one of the most common serious injuries associated with Saxenda use.
Does the amount of weight I lost affect my case?
While rapid weight loss can contribute to gallstone formation, the clinical trial data for Saxenda shows gallbladder events at rates higher than would be expected from weight loss alone. An attorney can evaluate whether your case supports a claim against Novo Nordisk.
What is post-cholecystectomy syndrome?
Post-cholecystectomy syndrome refers to ongoing digestive symptoms that some patients experience after gallbladder removal, including diarrhea, bloating, and food intolerance. These symptoms can be permanent and may be included in your compensation.
How long do I have to file a Saxenda lawsuit?
The statute of limitations varies by state, typically ranging from 1 to 6 years from the date of your injury or the date you discovered the connection between your injury and Saxenda. Consult with an attorney promptly to protect your rights.
Can I file a claim if I still have my gallbladder but have gallbladder disease?
Yes. You do not need to have had your gallbladder removed to file a claim. If you developed gallstones, gallbladder inflammation, or other gallbladder disease after taking Saxenda, you may have a valid case.